ImmunoCellular Therapeutics
| Region | Nordamerika |
| ISIN | US4525362046 |
| Sektor | Biotechnologie |
| Website | http://www.imuc.com/ |
ImmunoCellular Therapeutics, Ltd. , based in Los Angeles, is developing immune-based therapies for the treatment of cancer. ImmunoCellular is focused on advancing its Stem-to-T-Cell research program, which engineers hematopoietic stem cells to generate cytotoxic T cells.
| Titel | Datum |
|---|---|
| MISC's 2Q25 Net Profit Slips 14% To RM464.4 Million On Weaker Engineering And Gas Segments | vor 24 Tagen |
| MISC's Net Profit Down 7.1% To RM1.2 Billion On Lower Revenue | vor 24 Tagen |
| MISC's 2Q profit down 14% on weaker gas and marine ops, declares eight sen dividend | vor 24 Tagen |
| Bumi Armada-MISC merger falls through | vor ungefähr einem Monat |
| Insider Moves: Eduspec Holdings Bhd, CB Industrial Product Holding Bhd, MISC Bhd, Oasis Harvest Corp Bhd | vor ungefähr einem Monat |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Idea Fabrik (3 Artikel) | |
| Iconic Minerals (2 Artikel) | |
| Incyte (1 Artikel) | |
| India Globalization Capital (2 Artikel) | |
| Alle anzeigen | |